- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The US government’s sharp tariff hike on China to 125%, alongside 10% baseline tariffs for most partners, is sending shockwaves through the medtech sector. While rising costs and supply chain risks threaten innovation, tariffs may spur investment in US-made devices. With the right incentives, reshoring production could attract venture capital investor interest, though risks vary […]
Sun Pharma’s Leqselvi has potential for rapid uptake in US alopecia areata market, says GlobalData
Following the overturn of Leqselvi’s injunction in the US market on 10 April 2025: Vinie Varkey, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “Sun Pharma’s Leqselvi has a strong chance to see quick patient uptake in the US. The JAK 1/2 inhibitor was approved by the FDA in July […]
Trump’s tariff U-turn drives 550% surge in influencer debate amid deep divide, finds GlobalData
President Donald Trump hit a 90-day pause on tariffs for key US trade partners, except China. The unexpected move reversed his hardline stance, triggered a market rally, and eased global trade tensions. Consequently, the conversation related to ‘Tariffs’ among the influencers week-on-week surged by 550%, in the second week of April, reveals the Social Media […]
JP Morgan and Houlihan Lokey top M&A financial advisers by value and volume in Q1 2025, finds GlobalData
JP Morgan and Houlihan Lokey have emerged as the top mergers and acquisitions (M&A) financial advisers by value and volume for Q1 2025 in the latest Financial Advisers League Table by GlobalData, which ranks financial advisers by the value and volume of M&A deals on which they advised. Based on its Deals Database, the leading […]
Multiplay service revenue in India to grow at 4.2% CAGR during 2024-2029, forecasts GlobalData
Multiplay service revenue in India is expected to grow at a steady compound annual growth rate (CAGR) of 4.2% from $2.4 billion in 2024 to $3 billion in 2029, in line with the continued growth in the number of multiplay households, forecasts GlobalData, a leading data and analytics company. The ongoing fiber-optic network expansions by […]
Kirkland & Ellis was the top M&A legal adviser in Q1 2025, finds GlobalData
Kirkland & Ellis has emerged as the top mergers and acquisitions (M&A) legal adviser in Q1 2025 in terms of both value and volume on the latest Legal Advisers League Table by GlobalData, which ranks legal advisers by the value and volume of mergers and acquisition (M&A) deals on which they advised. Based on its […]
APAC automakers face uncertainty as US tariffs trigger strategic recalibration, finds GlobalData
The 25% US tariff on foreign automobiles and parts has created deep uncertainty for Asia-Pacific (APAC) automakers. With significant exposure to the US market, they now face rising costs, strained supply chains, and pressure to shift production. The temporary 90-day hold on the updated tariff, announced on 09 April 2025, offers a brief respite while […]
Rafale-M procurement a strategic necessity for Indian Navy, says GlobalData
Following the news that India has approved the procurement of 26 Rafale-M (Marine) fighter aircraft for the Indian Navy: Udayini Aakunoor, Defense Analyst at GlobalData, a leading data and analytics company, offers her view: “The Indian Navy is set to significantly enhance its carrier-based air combat capabilities with Rafale Marine aircraft from France’s Dassault. The […]
Axsome Therapeutics’ AXS-05 challenges current standard of care as promising non-antipsychotic for Alzheimer’s agitation, says GlobalData
At the recently held American Academy of Neurology (AAN) 2025 annual meeting, Axsome Therapeutics presented promising data for AXS-05 (bupropion + dextromethorphan) in treating agitation associated with Alzheimer’s disease (AD). With a novel, non-antipsychotic mechanism and a favorable safety profile, AXS-05 addresses a critical unmet need in managing distressing behavioral symptoms, potentially reshaping the current […]
India and Japan offer hope amid 6% decline in global deal activity in Q1 2025, reveals GlobalData
The global deal landscape (mergers & acquisitions (M&A), private equity and venture financing deals) declined 6% year-on-year (YoY) during the first quarter (Q1) of 2025, as economic uncertainty weighed on investor confidence. However, markets like India and Japan stood out by defying the global trend, signaling that select regions continue to attract deal-makers despite broader […]
Coronary stents market in APAC to see sustained growth through 2034, forecasts GlobalData
The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery disease (CAD) prevalence, an aging population, and increased access to healthcare. Against this backdrop, the market is poised to grow at a compound annual growth rate (CAGR) of 3.2% in APAC between 2024 and 2034, outpacing the […]
US tariffs trigger strategic shift in global enterprise tech investments and AI talent dynamics, says GlobalData
The US tariffs introduced under the Trump administration are prompting enterprise technology firms to rethink their strategies amid rising costs and economic uncertainty. Beyond immediate IT budget pressures, these policy shifts are driving changes in supply chains, vendor diversification, and sourcing models, ultimately reshaping global tech investments and intensifying challenges around AI talent mobility and […]
Buntanetap shows promise in early Parkinson’s with mild dementia, says GlobalData
At the recently held AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (PD), Annovis Bio reported buntanetap’s potential to improve both motor and cognitive functions in early-stage PD patients with mild dementia. This underscores the growing need for effective dementia treatments in PD, noting the drug’s promising sub-group outcomes as a critical step in […]
Top 25 global insurers market value up 17% YoY in Q1 2025, reveals GlobalData
PICC Property and Casualty and Assicurazioni Generali shares surge 40% Elevance Health and Cigna Group lose over 15% Berkshire Hathaway retains top spot The aggregate market capitalization (MCap) of the top 25 global insurers grew 17% to $3.5 trillion year-on-year (YoY) during the first quarter (Q1) ended on 31 March 2025. Most of the stocks […]
Large pharma drug licensing from China reaches record high at 28% in 2024, reveals GlobalData
Licensing agreements for Chinese drug candidates hit a record high in 2024, with large pharma in-licensing 28% of innovator drugs from Chinese biopharma companies. Total deal values of innovator drug licensing agreements involving Chinese biopharma licensors surged 66%, from $16.6 billion in 2023 to $41.5 billion in 2024, marking a five-year high, according to GlobalData, […]
Indonesia card payments market to reach $87 billion in 2029, forecasts GlobalData
The Indonesia card payments market is forecast to register a compound annual growth rate (CAGR) of 8.8% between 2025 and 2029 to reach IDR1,379.4 trillion ($87 billion) in 2029, supported by the constant consumer shift towards electronic payments, according to GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that card payment […]
DHTs promise detection of disease progression in early PD patients receiving symptomatic treatment, says GlobalData
At the recently held AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases, Roche outlined the effectiveness of digital health technologies (DHTs) in providing more sensitive measures of disease progression in early Parkinson’s disease (PD). There are no pathological or imaging-based biomarkers to measure a PD patient’s progression. Instead, physicians rely on clinical examinations and […]
APAC top 50 market cap hits $8.3 trillion in Q1 2025 as tech titans drive growth amid mixed regional outlook, reveals GlobalData
The combined market capitalization of the top 50 companies in the Asia-Pacific (APAC) region surged to $8.3 trillion for the quarter ended 31 March 2025 (Q1), reflecting a 14% year-on-year increase. Technology firms led the charge, with Taiwan Semiconductor Manufacturing Company (TSMC) and Tencent Holdings dominating the rankings, while traditional sectors like automotive and energy […]
US tariffs on Vietnamese imports trigger strategic pivot as growth forecast trimmed to 6.5% for 2025: GlobalData
Following the news that the 10% US import tariff, including a 46% hike specifically targeting Vietnamese goods, will take effect on 09 April 2025; Annapurna Pillutla, Analyst, Economic Research at GlobalData, a leading data and analytics company, offers her view: “In response to the US tariffs, Vietnam reaffirmed its commitment to fair trade and transparency. […]
GlobalData forecasts uveitis market across 7MM to reach $1.5 billion
The uveitis market in the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is set to grow from $522.5 billion in 2023 to $1.5 billion in 2033, driven by the entry of therapies with new mechanisms of action and route of administration into the market, as well as the […]